CASELLI, Emilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.849
AS - Asia 3.448
EU - Europa 3.349
SA - Sud America 470
AF - Africa 63
OC - Oceania 5
Totale 14.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.741
CN - Cina 1.097
SG - Singapore 1.089
IT - Italia 902
GB - Regno Unito 790
SE - Svezia 505
HK - Hong Kong 427
BR - Brasile 377
DE - Germania 233
VN - Vietnam 232
RU - Federazione Russa 191
KR - Corea 158
UA - Ucraina 152
TR - Turchia 119
FR - Francia 99
FI - Finlandia 79
IN - India 73
BG - Bulgaria 63
CA - Canada 59
BE - Belgio 57
ID - Indonesia 55
NL - Olanda 51
IE - Irlanda 49
JP - Giappone 49
PL - Polonia 42
BD - Bangladesh 40
MX - Messico 38
ES - Italia 33
RO - Romania 30
AR - Argentina 29
ZA - Sudafrica 20
AT - Austria 18
IQ - Iraq 16
LT - Lituania 16
MA - Marocco 15
EC - Ecuador 14
CL - Cile 12
CO - Colombia 12
MY - Malesia 12
AE - Emirati Arabi Uniti 9
PK - Pakistan 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
AZ - Azerbaigian 7
KZ - Kazakistan 7
PE - Perù 6
TW - Taiwan 6
DZ - Algeria 5
MD - Moldavia 5
SC - Seychelles 5
CH - Svizzera 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
NO - Norvegia 4
PH - Filippine 4
PY - Paraguay 4
TN - Tunisia 4
AL - Albania 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EG - Egitto 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
QA - Qatar 3
AU - Australia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GY - Guiana 2
KG - Kirghizistan 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
AM - Armenia 1
CG - Congo 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
LU - Lussemburgo 1
MT - Malta 1
NR - Nauru 1
OM - Oman 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
Totale 14.182
Salva come PNG Salva come JPEG
Città #
Santa Clara 759
Singapore 667
Ashburn 548
Chandler 517
Fairfield 475
Hefei 454
Woodbridge 448
Hong Kong 420
Southend 419
Jacksonville 302
Ann Arbor 263
Nyköping 262
Houston 238
London 208
Dearborn 206
Seattle 195
Cambridge 192
Wilmington 190
Modena 172
Beijing 150
Dallas 126
Los Angeles 118
Chicago 103
Seoul 101
Ho Chi Minh City 74
Council Bluffs 72
Princeton 61
Sofia 61
New York 56
Hanoi 54
Milan 54
San Diego 53
Redwood City 52
Eugene 48
Des Moines 47
Dublin 46
Shanghai 44
São Paulo 42
Izmir 41
The Dalles 40
Jakarta 39
Moscow 38
Salt Lake City 38
Reggio Emilia 37
Brussels 36
Buffalo 33
Parma 32
Tokyo 32
Warsaw 32
Amsterdam 29
Munich 28
Yalova 28
Bologna 27
Helsinki 27
Frankfurt am Main 26
Phoenix 24
Brooklyn 23
San Jose 22
Florence 21
Timisoara 21
Boardman 20
Elk Grove Village 20
Mexico City 20
Tampa 20
Turin 20
Falls Church 19
Menlo Park 19
Nuremberg 19
Columbus 18
Guangzhou 18
Pedara 18
Fuzhou 17
Bremen 16
Fremont 16
Kent 16
Chennai 15
Formigine 15
Orem 15
Seongnam 15
Atlanta 14
Boston 14
Denver 14
Dong Ket 14
Ghent 14
Norwalk 13
Johannesburg 12
Redondo Beach 12
San Francisco 12
Toronto 12
Vancouver 12
Washington 12
Kunming 11
Montreal 11
Nanjing 11
Rio de Janeiro 11
Rome 11
Salvador 11
Poplar 10
Pune 10
Verona 10
Totale 9.558
Salva come PNG Salva come JPEG
Nome #
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening 887
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 608
Chemo-enzymatic synthesis of levodropropizine 348
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 338
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 327
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 319
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 313
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 308
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 293
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 289
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 281
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 280
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 277
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 264
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 263
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 246
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 246
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 244
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 240
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 238
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 235
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 233
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 228
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 221
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 221
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 220
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 218
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 218
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 215
Structure-based design and in-parallel synthesis of inhibitors of AmpC β-lactamase 207
Nanomolar inhibitors of AmpC beta-lactamase 204
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 203
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 203
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 201
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 198
Using Boronic Acid Transition State Inhibitors to understand the extended spectrum (ES) and carbapenemase phenotypes of class A beta-lactamases in Klebsiella pneumoniae 195
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 195
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 187
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 185
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase 184
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 183
Exploring novel inhibitors of FOX-4 Class C β-lactamase 182
Structure-based optimization of cephalotin analogue boronic acids as beta-lactamase inhibitors 180
Stereoselective synthesis of erythro beta-substituted aspartates 178
Recognition and resistance in TEM beta-lactamase 172
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases 171
Structures of FOX-4 cephamycinase in complex with transition-state analog inhibitors 167
Inhibition of the Class C β-Lactamase from Acinetobacter spp.: Insights into Effective Inhibitor Design 161
Structure-Based Design and In Parallel Synthesis of Boronic Acid Inhibitors of AmpC 61538;-Lactamase 155
Structure-based design and solid phase synthesis of novel AmpC b-lactamase inhibitors 152
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs 149
Progettazione, Sintesi ed Attività di Acidi 1-Acilamminoalcanboronici Inibitori di beta-Lattamasi 147
Interactions of Oxyimino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42 142
The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV β-lactamase: A study of Ambler position Asn276 140
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum 137
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates 137
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii 136
Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog 129
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 128
Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor 127
Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry 100
Structural Studies of Inhibition of β-Lactamases by Boronic Acid Transition State Analogs and a Penam Sulfone 90
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas-derived cephalosporinase 85
Restoring cefepime activity against multidrug-resistant KPC-producing Klebsiella pneumoniae by combination with boronic acid inhibitors, MB076 and S02030 67
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant Acinetobacter baumannii (CRAb) 61
Boronate-Based Inhibitors of Penicillin-Binding Proteins: An Underestimated Avenue for Antibiotic Discovery? 58
Totale 14.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021940 0 0 0 0 0 171 119 139 124 201 107 79
2021/20221.248 81 116 86 106 68 109 48 88 144 88 187 127
2022/20231.532 186 174 113 161 173 222 38 120 180 20 55 90
2023/2024988 38 76 49 104 186 92 143 78 26 32 53 111
2024/20253.060 110 65 70 178 536 456 205 228 301 84 337 490
2025/20263.386 376 334 587 784 876 429 0 0 0 0 0 0
Totale 14.314